← SynDRA
TOFOGLIFLOZIN ANHYDROUS
SynDRA canonical compound SYN0033401 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | GCK | SLC5A2 |
|---|
| Mechanism of action | sodium/glucose cotransporter inhibitor |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- SLC5A2 INHIBITOR
- Sodium/glucose cotransporter 2 inhibitor
- sodium/glucose cotransporter inhibitor
- SLC5A2 MODULATOR
Drug classes
- Hypoglycemic Agents
- Sodium-Glucose Transporter 2 Inhibitors
Cross-references
Synonyms
- tofogliflozin
- tofogliflozin hydrate
- deberza
- apleway
- CSG452
- CSG-452
- R-7201
- RO-4998452
- RO4998452
- Type 2 diabetes therapeutic (oral), Roche
- TOFOGLIFLOZIN
- Tofogliflozina
- Tofogliflozine
- tofogliflozinum
- RefChem:933166
- DTXCID10160588
- P8DD8KX4O4
- Tofogliflozin [INN]
- Tofogliflozin anyhydrous
- UNII-554245W62T
- CSG452 ANHYDROUS
- TOFOGLIFLOZIN [MI]
- EC 619-989-0
- CSG-452 ANHYDROUS
- R-7201 ANHYDROUS
- SCHEMBL903156
- TOFOGLIFLOZIN [WHO-DD]
- GTPL9395
- orb1708343
- SCHEMBL29358428
- RO4998452 ANHYDROUS
- CHEBI:136041
- RO-4998452 ANHYDROUS
- BDBM50396779
- AKOS027250822
- FT28301
- compound 16d [PMID: 22889351]
- NCGC00485920-01
- AC-31468
Look up TOFOGLIFLOZIN ANHYDROUS in the interactive SynDRA portal →